IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?

Background CD4 lymphocyte cell count represents the main immunological marker used to monitor HIV infection. However, frequent monitoring may be unnecessary, could cause anxiety to the patient as well as burdening healthcare with extra expenses.   Objectives and methods To analyse the pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Benedetto Maurizio Celesia, Dr., Andrea Marino, Dr., Rosa Fontana del Vecchio, Dr., Roberto Bruno, Dr., Filippo Palermo, Professor, Maria Gussio, Dr., Giuseppe Nunnari, Professor, Bruno Cacopardo, Professor
Format: Article
Language:English
Published: PAGEPress Publications 2019-10-01
Series:Mediterranean Journal of Hematology and Infectious Diseases
Subjects:
CD4, HIV monitoring, safe HIV Management
Online Access:http://mjhid.org/index.php/mjhid/article/view/4019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items